Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

被引:278
作者
Allen, TM
Altfeld, M
Geer, SC
Kalife, ET
Moore, C
O'Sullivan, KM
DeSouza, I
Feeney, ME
Eldridge, RL
Maier, EL
Kaufmann, DE
Lahaie, MP
Reyor, L
Tanzi, G
Johnston, MN
Brander, C
Draenert, R
Rockstroh, JK
Jessen, H
Rosenberg, ES
Mallal, SA
Walker, BD
机构
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Partners AIDS Res Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Div Infect Dis, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA
[4] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia
[5] Jessen Praxis, Berlin, Germany
[6] Univ Bonn, Dept Internal Med, D-5300 Bonn, Germany
关键词
D O I
10.1128/JVI.79.21.13239-13249.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The sequence diversity of human immunodeficiency virus type 1 (HIV-1) represents a major obstacle to the development of an effective vaccine, yet the forces impacting the evolution of this pathogen remain unclear. To address this issue we assessed the relationship between genome-wide viral evolution and adaptive CD8(+) T-cell responses in four clade B virus-infected patients studied longitudinally for as long as 5 years after acute infection. Of the 98 amino acid mutations identified in nonenvelope antigens, 53% were associated with detectable CD8(+) T-cell responses, indicative of positive selective immune pressures. An additional 18% of amino acid mutations represented substitutions toward common clade B consensus sequence residues, nine of which were strongly associated with HLA class I alleles not expressed by the subjects and thus indicative of reversions of transmitted CD8 escape mutations. Thus, nearly two-thirds of all mutations were attributable to CD8(+) T-cell selective pressures. A closer examination of CD8 escape mutations in additional persons with chronic disease indicated that not only did immune pressures frequently result in selection of identical amino acid substitutions in mutating epitopes, but mutating residues also correlated with highly polymorphic sites in both clade B and C viruses. These data indicate a dominant role for cellular immune selective pressures in driving both individual and global HIV-1 evolution. The stereotypic nature of acquired mutations provides support for biochemical constraints limiting HIV-1 evolution and for the impact of CD8 escape mutations on viral fitness.
引用
收藏
页码:13239 / 13249
页数:11
相关论文
共 57 条
  • [1] The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
    Addo, MM
    Altfeld, M
    Rosenberg, ES
    Eldridge, RL
    Philips, MN
    Habeeb, K
    Khatri, A
    Brander, C
    Robbins, GK
    Mazzara, GP
    Goulder, PJR
    Walker, BD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1781 - 1786
  • [2] RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA
    ALBERT, J
    ABRAHAMSSON, B
    NAGY, K
    AURELIUS, E
    GAINES, H
    NYSTROM, G
    FENYO, EM
    [J]. AIDS, 1990, 4 (02) : 107 - 112
  • [3] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [4] Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection
    Allen, TM
    Altfeld, M
    Yu, XG
    O'Sullivan, KM
    Lichterfeld, M
    Le Gall, S
    John, M
    Mothe, BR
    Lee, PK
    Kalife, ET
    Cohen, DE
    Freedberg, KA
    Strick, DA
    Johnston, MN
    Sette, A
    Rosenberg, ES
    Mallal, SA
    Goulder, PJR
    Brander, C
    Walker, BD
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (13) : 7069 - 7078
  • [5] HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
    Altfeld, M
    Allen, TM
    Yu, XG
    Johnston, MN
    Agrawal, D
    Korber, BT
    Montefiori, DC
    O'Connor, DH
    Davis, BT
    Lee, PK
    Maier, EL
    Harlow, J
    Goulder, PJR
    Brander, C
    Rosenberg, ES
    Walker, BD
    [J]. NATURE, 2002, 420 (6914) : 434 - 439
  • [6] Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
    Altfeld, M
    Addo, MA
    Rosenberg, ES
    Hecht, FA
    Lee, PK
    Vogel, M
    Yu, XG
    Draenert, R
    Johnston, MN
    Strick, D
    Allen, TA
    Feeney, ME
    Kahn, JO
    Sekaly, RP
    Levy, JA
    Rockstroh, JK
    Goulder, PJR
    Walker, BD
    [J]. AIDS, 2003, 17 (18) : 2581 - 2591
  • [7] Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences
    Altfeld, M
    Addo, MM
    Shankarappa, R
    Lee, PK
    Allen, TM
    Yu, XG
    Rathod, A
    Harlow, J
    O'Sullivan, K
    Johnston, MN
    Goulder, PJR
    Mullins, JI
    Rosenberg, ES
    Brander, C
    Korber, B
    Walker, BD
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (13) : 7330 - 7340
  • [8] Vpr is preferentially targeted by CTL during HIV-1 infection
    Altfeld, M
    Addo, MM
    Eldridge, RL
    Yu, XG
    Thomas, S
    Khatri, A
    Strick, D
    Phillips, MN
    Cohen, GB
    Islam, SA
    Kalams, SA
    Brander, C
    Goulder, PJR
    Rosenberg, ES
    Walker, BD
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (05) : 2743 - 2752
  • [9] ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
  • [10] Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
    Barouch, DH
    Kunstman, J
    Kuroda, MJ
    Schmitz, JE
    Santra, S
    Peyerl, FW
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Gorgone, DA
    Montefiori, DC
    Lewis, MG
    Wolinsky, SM
    Letvin, NL
    [J]. NATURE, 2002, 415 (6869) : 335 - 339